A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice

Vaccines targeting SARS-CoV-2 have been shown to be highly effective; however, the breadth against emerging variants and the longevity of protection remains unclear. Postimmunization boosting has been shown to be beneficial for disease protection, and as new variants continue to emerge, periodic (an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaparian, Ryan R., Harding, Alfred T., Hamele, Cait E., Riebe, Kristina, Karlsson, Amelia, Sempowski, Gregory D., Heaton, Nicholas S., Heaton, Brook E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364787/
https://www.ncbi.nlm.nih.gov/pubmed/35862698
http://dx.doi.org/10.1128/jvi.00689-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364787/
https://www.ncbi.nlm.nih.gov/pubmed/35862698
http://dx.doi.org/10.1128/jvi.00689-22

Ejemplares similares